MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

Phase 2
Completed
Conditions
Hypertension, Pulmonary
Pulmonary Fibrosis
First Posted Date
2006-07-14
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
20
Registration Number
NCT00352482
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCLA Pulmonary Outpatient Clinic,, Los Angeles, California, United States

Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia

Phase 2
Completed
Conditions
T-LGL Lymphoproliferative Disorders
Interventions
Biological: Alemtuzumab (Campath)
First Posted Date
2006-06-28
Last Posted Date
2022-05-03
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
29
Registration Number
NCT00345345
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Identifying Genes That May Increase the Risk for Heart Disease in African Americans

Completed
Conditions
Heart Diseases
First Posted Date
2006-06-26
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
5302
Registration Number
NCT00344136
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Mississippi School of Medicine, Jackson, Mississippi, United States

Genomics of In-Stent Restenosis

Completed
Conditions
Vascular Disease
In-Stent Restenosis
First Posted Date
2006-06-21
Last Posted Date
2008-03-04
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
30
Registration Number
NCT00341562
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States

Coated Endotracheal Tube and Mucus Shaver to Prevent Hospital-Acquired Infections

Phase 2
Completed
Conditions
Infection
First Posted Date
2006-06-21
Last Posted Date
2017-07-02
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
24
Registration Number
NCT00341354
Locations
๐Ÿ‡ฎ๐Ÿ‡น

Hospital San Gerardo di Monza, University of Bicocca Monza, Milan, Italy

A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study

Completed
Conditions
Genetics
First Posted Date
2006-06-21
Last Posted Date
2019-12-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
1888
Registration Number
NCT00340509
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike, Bethesda, Maryland, United States

Effect of Air Pollution on Long-Term Asthma Severity and Lung Function in Children

Conditions
Asthma
First Posted Date
2006-06-12
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
315
Registration Number
NCT00336050

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Phase 3
Completed
Conditions
Lymphoma, B-Cell
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Interventions
Drug: Autologous transplantation using rituxan/BEAM
Drug: Autologous transplantation using Bexxar/BEAM
First Posted Date
2006-05-24
Last Posted Date
2021-11-01
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
224
Registration Number
NCT00329030
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Maryland Medical Systems/Greenbaum Cancer Center, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Loyola University Medical Center, Maywood, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Washington University/Barnes Jewish Hospital, Saint Louis, Missouri, United States

and more 33 locations

Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease

Phase 3
Completed
Conditions
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Interventions
Behavioral: Lifestyle Activity Program
Behavioral: Exercise Program
First Posted Date
2006-05-22
Last Posted Date
2016-07-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
318
Registration Number
NCT00328484
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Wake Forest University, Winston-Salem, North Carolina, United States

Sildenafil to Treat HIV-Associated Pulmonary Hypertension

Phase 1
Terminated
Conditions
HIV
First Posted Date
2006-05-18
Last Posted Date
2019-12-17
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
20
Registration Number
NCT00327080
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath